Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Olympus Corp (OLYMY)

Olympus Corp (OLYMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.2400 +4.63%
on 12/19/24
16.2900 -8.53%
on 12/06/24
-0.9800 (-6.17%)
since 12/03/24
3-Month
14.2400 +4.63%
on 12/19/24
19.6900 -24.33%
on 10/10/24
-3.8100 (-20.36%)
since 10/03/24
52-Week
13.1300 +13.48%
on 02/14/24
19.6900 -24.33%
on 10/10/24
+0.7500 (+5.30%)
since 01/03/24

Most Recent Stories

More News
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year

Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year

OLYMY : 14.9000 (+0.27%)
OCPNF : 15.5000 (-0.80%)
NTT and Olympus Demonstrate IOWN APN Low-latency Capability can be Used for Real-time Diagnosis and Treatment on Remote Server to Realize World's First Cloud Endoscopy System

NTT and Olympus Demonstrate IOWN APN Low-latency Capability can be Used for Real-time Diagnosis and Treatment on Remote Server to Realize World's First Cloud Endoscopy System

OLYMY : 14.9000 (+0.27%)
OCPNF : 15.5000 (-0.80%)
Olympus Launches VISERA S, a New Imaging Platform

Olympus Launches VISERA S, a New Imaging Platform

OLYMY : 14.9000 (+0.27%)
OCPNF : 15.5000 (-0.80%)
Olympus Launches New 4K Camera Head for Urological Endoscopy

Olympus Launches New 4K Camera Head for Urological Endoscopy

SONY : 21.32 (+1.09%)
OLYMY : 14.9000 (+0.27%)
OCPNF : 15.5000 (-0.80%)
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India

Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India

OCPNF : 15.5000 (-0.80%)
OLYMY : 14.9000 (+0.27%)
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System

NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System

NPPXF : 1.0320 (-0.86%)
NTTYY : 24.9400 (-0.20%)
OCPNY : 18.0000 (-1.37%)
OCPNF : 15.5000 (-0.80%)
OLYMY : 14.9000 (+0.27%)
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.5000 (-0.80%)
OLYMY : 14.9000 (+0.27%)
Olympus Names Dr. John de Csepel as Chief Medical Officer

Olympus Names Dr. John de Csepel as Chief Medical Officer

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.5000 (-0.80%)
OLYMY : 14.9000 (+0.27%)
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases

Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.5000 (-0.80%)
OLYMY : 14.9000 (+0.27%)
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision

Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision

OCPNY : 18.0000 (-1.37%)
OCPNF : 15.5000 (-0.80%)
OLYMY : 14.9000 (+0.27%)

Key Turning Points

3rd Resistance Point 15.0867
2nd Resistance Point 15.0133
1st Resistance Point 14.9567
Last Price 14.9000
1st Support Level 14.8267
2nd Support Level 14.7533
3rd Support Level 14.6967

See More

52-Week High 19.6900
Fibonacci 61.8% 17.1841
Fibonacci 50% 16.4100
Fibonacci 38.2% 15.6359
Last Price 14.9000
52-Week Low 13.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar